Sort
141,003 grants matching “cytokine”
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
$620,783Jayakrishna Ambati · University Of Virginia · R01 · FY2024 · AG
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
$620,783Jayakrishna Ambati · University Of Virginia · R01 · FY2022 · AG
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
$620,783Jayakrishna Ambati · University Of Virginia · R01 · FY2023 · AG
Reversing Age Related Inflammation
$620,775Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R01 · FY2019 · NS
Impact of Inflammation on Adult Prostate Stem Cells
$620,771Timothy L Ratliff · Purdue University · R01 · FY2020 · DK
Dendritic cell-based vaccination against hepatitis C
$620,745Stephen H. Gregory · University Of Rhode Island · U19 · FY2011 · AI
IMMUNOBIOLOGY OF VARICELLA AND ZOSTER IN A PRIMATE MODEL
$620,741Ravi Mahalingam · University Of Colorado Denver · P01 · FY2013 · AG
Lnk Regulatory Functions in Hematopoietic Stem Cells
$620,738Wei Tong · Children'S Hosp Of Philadelphia · R01 · FY2019 · HL
Developing novel therapies to improve blood stem cell transplantation outcomes
$620,713Ramiro Garzon · University Of Utah · R01 · FY2024 · HL
Project 1: Bidirectional interactions between TIGIT and CD155 in regulating tissue tolerance
$620,690Vijay K Kuchroo · Yale University · P01 · FY2024 · AI
Project 1: Bidirectional interactions between TIGIT and CD155 in regulating tissue tolerance
$620,690Vijay K Kuchroo · Yale University · P01 · FY2023 · AI
Project 1: Bidirectional interactions between TIGIT and CD155 in regulating tissue tolerance
$620,688Vijay K Kuchroo · Yale University · P01 · FY2025 · AI
Phase 1 Evaluation of Enhanced Natural Killer Cells as a Treatment Strategy in Non-Small cell Lung Cancer Patients Refractory to PD-1/PD-L1 Immune Checkpoint Inhibitors
$620,673Miguel Angel Villalona · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Identifying senescence and immune biomarkers predictive of benefit to combined CDK4 and checkpoint blockade inhibition in patients with dedifferentiated liposarcoma
$620,672Sandra P D'angelo · Sloan-Kettering Inst Can Research · R01 · FY2024 · FD
Mechanisms underlying regulation of intestinal epithelial homeostasis in sepsis
$620,672Xiao-Di Tan · Lurie Children'S Hospital Of Chicago · R01 · FY2021 · DK
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis
$620,650Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis
$620,650Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis
$620,650Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
GM-CSF, macrophages, and susceptibility to Mycobacterium abscessus pulmonary infection
$620,636Katherine B Hisert · National Jewish Health · R01 · FY2025 · HL
Biology of trabecular response to laser trabeculoplasty
$620,631Ted S Acott · Oregon Health & Science University · R01 · FY2011 · EY
Biology of trabecular response to laser trabeculoplasty
$620,631Ted S Acott · Oregon Health & Science University · R01 · FY2012 · EY
Neutrophil Survival and Demise During Inflammatory States
$620,629Harold M Hoffman · Scripps Research Institute, The · P01 · FY2022 · HL
Histamine Receptor Signaling in CNS Autoimmune Disease
$620,629Cory Teuscher · University Of Vermont & St Agric College · R01 · FY2009 · NS
Age, Gene/Environment Susceptibility Study
$620,622Tamara Harris · Aging · Z01 · FY2007 · AG
Parenchymal border macrophages in AD and CAA
$620,596Jonathan Kipnis · Washington University · P01 · FY2024 · AG